By Fineline Cube 
Boston Scientific (NYSE: BSX) has announced FDA 510(k) clearance for its Asurys Fluid Management System, a specialized device designed to provide irrigation and distension for endoscopic urology procedures, including ureteroscopy. The system integrates with Boston Scientific’s StoneSmart solutions ecosystem and pairs with the LithoVue Elite single-use digital flexible ureteroscope to enhance intrarenal pressure (IRP) management during kidney stone treatments.
Regulatory Approval Summary
| Parameter | Detail |
|---|---|
| Company | Boston Scientific (NYSE: BSX) |
| Device | Asurys Fluid Management System |
| Regulatory Status | FDA 510(k) cleared |
| Primary Indication | Irrigation and distension for endoscopic urology procedures |
| Key Procedure | Ureteroscopy for kidney stone management |
| Integration Platform | StoneSmart solutions ecosystem |
| Companion Device | LithoVue Elite single-use digital flexible ureteroscope |
Technical Specifications & Innovation
- Fluid Management: Provides controlled irrigation and distension during endoscopic urology procedures
- IRP Monitoring Integration: Designed to work with LithoVue Elite’s intrarenal pressure (IRP) monitoring capabilities
- Pressure Management: Assists clinicians with real-time IRP management to maintain safe pressure levels during procedures
- Ecosystem Approach: Latest addition to Boston Scientific’s comprehensive StoneSmart kidney stone treatment platform
- Single-Use Compatibility: Optimized for use with disposable ureteroscopes, reducing cross-contamination risks
Clinical & Operational Benefits
| Stakeholder | Benefit |
|---|---|
| Urologists | Enhanced control over intrarenal pressure during stone procedures, improving patient safety |
| Hospitals/ASCs | Streamlined workflow through integrated StoneSmart ecosystem devices |
| Patients | Reduced procedural complications through better pressure management and single-use technology |
| Healthcare Systems | Potential cost savings from reduced procedure times and complication rates |
| Infection Control | Single-use ureteroscope eliminates reprocessing requirements and associated risks |
The integration of fluid management with real-time pressure monitoring addresses a critical safety concern in ureteroscopy, where elevated intrarenal pressure can lead to serious complications including sepsis and renal damage.
Market Impact Analysis
| Factor | Strategic Significance |
|---|---|
| Kidney Stone Prevalence | Affects 1 in 11 Americans; incidence increasing due to dietary and lifestyle factors |
| Ureteroscopy Volume | Over 1 million procedures performed annually in the US alone |
| Competitive Differentiation | Integrated IRP management represents significant advancement over standalone fluid systems |
| Ecosystem Lock-in | Strengthens Boston Scientific’s position in comprehensive stone management solutions |
| Reimbursement Environment | Single-use ureteroscopes increasingly favored by payers due to infection control benefits |
The global kidney stone management market is projected to exceed USD 3 billion by 2028, driven by rising prevalence and technological adoption.
Strategic Outlook
- Commercial Launch: Immediate availability in US market following FDA clearance
- Global Expansion: 510(k) clearance provides foundation for international regulatory submissions
- Platform Enhancement: Strengthens StoneSmart ecosystem’s competitive position against standalone device competitors
- Revenue Contribution: Expected to contribute meaningfully to Boston Scientific’s Endoscopy segment growth
- Clinical Adoption: Integration benefits likely to drive rapid adoption among high-volume stone centers
The Asurys system represents Boston Scientific’s continued investment in comprehensive, integrated solutions for complex urological procedures, leveraging the company’s leadership in both endoscopy and stone management technologies.
Forward‑Looking Statements
This brief contains forward-looking statements regarding Boston Scientific’s product commercialization and market expectations. Actual commercial performance may vary based on market adoption, competitive dynamics, and regulatory developments.-Fineline Info & Tech